MASSIVIT 3D PRTG TECHNOLOGIES Stock Price, News & Analysis

MSVTF OTC

Company Description

MASSIVIT 3D PRTG TECHNOLOGIES (OTC: MSVTF) is a publicly traded iron and steel forging company in the Manufacturing sector.

This page provides a comprehensive overview of MSVTF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

21.9M

Shares outstanding

Latest News

View All

November 2, 2023

0.00%

Massivit to Dazzle Formnext Expo Visitors with Live Demonstrations of the 10000-G Additive Manufacturing System on November 7-10

August 2, 2023

0.00%

Massivit to Participate in the 12th Annual Needham Industrial Tech, Robotics, & Clean Tech 1x1 Virtual Conference on August 7

conferences

July 24, 2023

0.00%

Massivit Releases Preliminary Q2 and H1 2023 Financial Results

earnings

May 8, 2023

0.00%

Massivit to Participate in the Inaugural EF Hutton Global Conference on May 10, 2023

conferences

April 24, 2023

0.00%

Massivit to Introduce Game-Changing 10000-G Additive Manufacturing System and Launch Corporate Rebranding at JEC World 2023

April 24, 2023

0.00%

Massivit to Introduce Game-Changing 10000-G Additive Manufacturing System and Launch Corporate Rebranding at JEC World 2023

MASSIVIT 3D PRTG TECHNOLOGIES has 7 recent news articles. Key topics include conferences, earnings. View all MSVTF news →

SEC Filings

View All

No SEC filings available for MSVTF.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MSVTF Company Profile & Sector Positioning

MASSIVIT 3D PRTG TECHNOLOGIES (MSVTF) operates in the Iron and Steel Forging industry within the broader Manufacturing sector and is listed on the OTC.